Jump to content

Biotechnology patent applications on 21st August 2025

From WikiPatents

Biotechnology Patent Applications on 21st August 2025

Executive Summary

On 21st August 2025, 170 patent applications related to Biotechnology were published, representing 2.6% of all patent applications for the day. This moderate level of activity shows Biotechnology is gaining significant attention from innovators.

Market Analysis

Leading Organizations

The top organizations driving Biotechnology innovation include:

Template:Newsletter signup box

These 5 organizations account for 37 applications (21.8% of all Biotechnology patents), indicating a diverse and competitive landscape.

Technology Deep Dive

Core Innovation Areas

Patent applications in Biotechnology encompass several key innovation areas:

Technical Classification Analysis

The most active CPC classifications in Biotechnology include:

  • C12N15/86 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 51 applications (30.0%)
  • C12N2750/14143 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 38 applications (22.4%)
  • C12N2310/141 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 26 applications (15.3%)
  • C12N2310/20 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 17 applications (10.0%)
  • C12N15/1138 ({against receptors or cell surface proteins}): 15 applications (8.8%)
  • C12N15/113 (Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants): 14 applications (8.2%)
  • C12N15/111 ({General methods applicable to biologically active non-coding nucleic acids}): 12 applications (7.1%)
  • C12N9/22 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 12 applications (7.1%)
  • C12Q1/6886 (for cancer (immunoassay for cancer): 12 applications (7.1%)
  • C12N9/226 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 11 applications (6.5%)

Global Innovation Landscape

Innovation in Biotechnology spans multiple countries:

  • US: 357 inventors (61.2%)
  • CA: 38 inventors (6.5%)
  • DE: 32 inventors (5.5%)
  • CN: 32 inventors (5.5%)
  • GB: 25 inventors (4.3%)
  • KR: 20 inventors (3.4%)
  • JP: 18 inventors (3.1%)
  • IT: 11 inventors (1.9%)
  • FR: 8 inventors (1.4%)
  • CH: 7 inventors (1.2%)

The US accounts for 61.2% of inventors in Biotechnology, indicating strong domestic innovation leadership.

Industry Collaborations

Notable collaborations in Biotechnology include:

These collaborations represent 5 joint applications, indicating emerging collaboration trends in Biotechnology.

Leading Inventors

Key inventors driving Biotechnology innovation:

Recent Patent Applications

Representative Biotechnology patent applications from 21st August 2025:

20250261603. METHODS OF MAKING FEMINIZED CANNABIS SATIVA SEED AND COMPOSITIONS THEREOF

Applicant: Floragen Llc

Abstract: The present disclosure relates to methods of producing viable

20250261635. COMPOSITIONS AND METHODS FOR SCALABLE PRODUCTION AND DELIVERY OF BIOLOGICALS

Applicant: Agrospheres Inc

Abstract: The present disclosure is generally directed to an agricultural formulation comprising an anucleated minicells and an anucleated cell-based platforms for encapsulation and scalable delivery of biologically active compounds. Disclosed herein are compositions for the stable and targeted delivery of biologically active compounds within achromosomal and/or anucleated cells onto and/or into a target cell. The present disclosure also provides methods of improving encapsulation and retention of biologi...

20250261650. INSECT INHIBITORY PROTEINS

Applicant: Monsanto Technology LLC

Abstract: Pesticidal proteins exhibiting toxic activity against Lepidopteran pest species are disclosed, and include, but are not limited to, TIC7941, TIC7941PL_1, TIC7941PL_2, and TIC7941PL_3. DNA constructs are provided which contain a recombinant nucleic acid sequence encoding one or more of the disclosed pesticidal proteins. Transgenic plants, plant cells, seed, and plant parts resistant to Lepidopteran infestation are provided which contain recombinant nucleic acid sequences encoding the pesticidal p...

20250261676. FUNGAL BIOMASS AND METHOD OF PRODUCING THEREOF

Applicant: Eniferbio Oy

Abstract: A method of producing a fungal biomass includes culturing genetically changed genomes of filamentous fungus on a medium, which has non-metabolizable glucose analogue and a growth carbon source comprising glycerol, isolating improved fungal strains from the cultured genetically changed genomes, wherein the improved fungal strains exhibit growth on the medium, pre-cultivating the isolated improved fungal strains, fermenting the pre-cultivated improved fungal strains with a feedstock to obtain a fe...

20250261884. ANALYTE SENSORS EMPLOYING MULTIPLE ENZYMES AND METHODS ASSOCIATED THEREWITH

Applicant: ABBOTT DIABETES CARE INC

Abstract: Methods and analyte sensors including at least a first working electrode having a first active area thereon, and performing a dip coating operation to deposit a bilayer membrane upon the first working electrode and the first active area. The bilayer may include an inner layer having a first membrane polymer and an outer layer having a second membrane polymer, the first membrane polymer and the second membrane polymer differing from one another. The dip coating operation may comprise one or more ...

Market Implications

Innovation Intensity

With 170 applications in a single day, Biotechnology demonstrates very high innovation intensity, suggesting rapid technological advancement and strong commercial interest.

Competitive Landscape

Innovation in Biotechnology involves 144 organizations, indicating a highly competitive and diverse landscape with many players investing in R&D.

Technology Outlook

Emerging themes in Biotechnology patents include: target, disclosure, that, biomolecule, acid, suggesting future development in these areas.

The current patent activity level suggests Biotechnology is in a growth phase with increasing market adoption and investment.

Related Technology Areas

Innovation in Biotechnology often intersects with other emerging technologies:

Analysis Tools

Search Resources

See Also

Retrieved from "https://wikipatents.org/index.php?title=Biotechnology_patent_applications_on_21st_August_2025&oldid=671155"
Cookies help us deliver our services. By using our services, you agree to our use of cookies.